Fig. 4From: Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysisForest plot of comparison of treatment with MRAs versus without MRAs on death from cardiovascular causes. Two studies evaluated the effect of MRAs on death from cardiovascular causes. Treatment with MRA-based regimens was associated with a statistically significant reduction in CV mortality compared with other treatments. Individually, in no study were observed statistically significant reductions in CV-cause mortalityBack to article page